The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation

• Egile Nagusiak: Chunxiao Lv (Egilea), Changxiao Liu (Egilea), Zhuhua Yao (Egilea), Xiumei Gao (Egilea), Lanjun Sun (Egilea), Jia Liu (Egilea), Haibo Song (Egilea), Ziqiang Li (Egilea), Xi Du (Egilea), Jinxia Sun (Egilea), Yanfen Li (Egilea), Kui Ye (Egilea), Ruihua Wang (Egilea), Yuhong Huang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2017-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Warfarin is used as anticoagulant and Compound Danshen prescription (CDP) is able to promote blood circulation. The combination might produce a synergic effect for patients of coronary heart diseases (CHDs) with atrial fibrillation (AF). Whether the combination increases the bleeding risk of warfari...